Examiner: SKELDING, ZACHARY S

Tech Center 1600 • Art Units: 1600 1644 1674

This examiner grants 60% of resolved cases

Performance Statistics

59.8%

Allow Rate

At TC average

864

Total Applications

+41.0%

Interview Lift

1330

Avg Prosecution Days

Based on 831 resolved cases, 2023–2026

2.8%

§101 Eligibility

14.5%

§102 Novelty

27.3%

§103 Obviousness

40.1%

§112 Clarity

App #	Title	Status	Assignee
18106567	CD6 ANTIBODY FOR TREATMENT OF T-CELL MEDIATED DISEASES OR DISORDERS	Non-Final OA	The Regents of the University of Michigan
18477532	CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT	Non-Final OA	The General Hospital Corporation
18142129	GLYCOENGINEERING	Non-Final OA	The General Hospital Corporation

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.